Previous experiments demonstrated that the transcriptional amplification system PSEBC-TSTA-fl is able to specifically quantify androgen receptor (AR) activity modulation in vitro and in vivo in prostate cancer cells [22, 23]. This evidence concerns the gene AR and Familial prostate cancer.